drugset / Trial / NCT06792695
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).
Timeline
- Start
- 2025-03-12
- Primary completion
- 2027-06-30
- Completion
- 2028-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Volrustomig | Monoclonal antibody | — | Intravenous |
| Background | Bevacizumab | Monoclonal antibody | — | Intravenous |
| Background | Irinotecan | Small molecule | — | Intravenous |
| Background | Leucovorin | Small molecule | — | Intravenous |
| Background | fluorouracil | Small molecule | — | Intravenous |